Jonathan C. Fox, See Remarks at Eidos Therapeutics, Inc. (EIDX), sold 15,000 shares at $50.26 ($730K) on 2019-11-18, disclosed to the SEC on 2019-11-19.
Open-market sale of $730k EIDX by See Remarks. Not flagged as scheduled, tax-driven, or recurring — but no specific bearish signal from our filters. Reasons for insider sales vary widely.
Nothing distinguishes this filing.
| # | Price | Shares | Value | % of Total |
|---|---|---|---|---|
| 1 | $44.88 | 2,000 | $90K | 12.3% |
| 2 | $45.51 | 2,100 | $96K | 13.1% |
| 3 | $46.45 | 900 | $42K | 5.7% |
| 4 | $50.26 | 10,000 | $503K | 68.9% |
| Total | $48.65 avg | 15,000 | $730K | 100% |
| Filing → |
| EIDX | SELL | 2020-09-18 | $579K | — | Filing → |
| EIDX | SELL | 2020-09-16 | $369K | — | Filing → |
| EIDX | SELL | 2020-07-09 | $250K | — | Filing → |